Nanoparticle-detained toxins for safe and effective vaccination (original) (raw)

• Kitchin, N. R. Review of diphtheria, tetanus and pertussis vaccines in clinical development. Exp. Rev. Vaccines 10, 605–615 (2011).
  Article CAS Google Scholar
• Greenberg, R. N., Marbury, T. C., Foglia, G. & Warny, M. Phase I dose finding studies of an adjuvanted Clostridium difficile toxoid vaccine. Vaccine 30, 2245–2249 (2012).
  Article CAS Google Scholar
• Mortimer, E. A. Jr. Immunization against infectious disease. Science 200, 902–907 (1978).
  Article Google Scholar
• Holmgren, J. et al. Development of improved cholera vaccine based on subunit toxoid. Nature 269, 602–604 (1977).
  Article CAS Google Scholar
• Gentschev, I., Dietrich, G. & Goebel, W. The E. coli alpha-hemolysin secretion system and its use in vaccine development. Trends Microbiol. 10, 39–45 (2002).
  Article CAS Google Scholar
• Cover, T. L. & Blanke, S. R. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nature Rev. Microbiol. 3, 320–332 (2005).
  Article CAS Google Scholar
• Bubeck Wardenburg, J. & Schneewind, O. Vaccine protection against Staphylococcus aureus pneumonia. J. Exp. Med. 205, 287–294 (2008).
  Article Google Scholar
• Parish, H. J. & Cannon, D. A. Staphylococcal infection: antitoxic immunity. Br. Med. J. 1, 743–747 (1960).
  Article CAS Google Scholar
• Metz, B. et al. Identification of formaldehyde-induced modifications in proteins: reactions with model peptides. J. Biol. Chem. 279, 6235–6243 (2004).
  Article CAS Google Scholar
• Cryz, S. J. Jr, Furer, E. & Germanier, R. Effect of chemical and heat inactivation on the antigenicity and immunogenicity of Vibrio cholerae. Infect. Immunol. 38, 21–26 (1982).
  Google Scholar
• Vogel, F. R. Improving vaccine performance with adjuvants. Clin. Infect. Dis. 30(Suppl 3), S266–S270 (2000).
  Article CAS Google Scholar
• Kennedy, A. D. et al. Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J. Infect. Dis. 202, 1050–1058 (2010).
  Article Google Scholar
• Adhikari, R. P. et al. Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumonia. PLoS One 7, e38567 (2012).
  Article CAS Google Scholar
• Jang, S. I. et al. Vaccination with Clostridium perfringens recombinant proteins in combination with Montanide ISA 71 VG adjuvant increases protection against experimental necrotic enteritis in commercial broiler chickens. Vaccine 30, 5401–5406 (2012).
  Article CAS Google Scholar
• Kirkham, L. A. et al. Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines. Infect. Immunol. 74, 586–593 (2006).
  Article CAS Google Scholar
• Hu, C. M. et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc. Natl Acad. Sci. USA 108, 10980–10985 (2011).
  Article CAS Google Scholar
• Hu, C. M., Fang, R., Copp, J., Luk, B. & Zhang, L. A biomimetic nanosponge that absorbs pore-forming toxins. Nature Nanotech. 8, 336–340 (2013).
  Article CAS Google Scholar
• Dobrovolskaia, M. A. & McNeil, S. E. Immunological properties of engineered nanomaterials. Nature Nanotech. 2, 469–478 (2007).
  Article CAS Google Scholar
• Moon, J. J. et al. Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses. Nature Mater. 10, 243–251 (2011).
  Article CAS Google Scholar
• Sun, C. et al. Circumventing anti-vector immunity using adenovirus-infected blood cells for repeated application of adenovirus vectored vaccines: proof-of-concept in rhesus macaques. J. Virol. 86, 11031–11042 (2012).
  Article CAS Google Scholar
• Roberts, D. M. et al. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity. Nature 441, 239–243 (2006).
  Article CAS Google Scholar
• Skean, J. D. & Overcast, W. W. Efficacy of staphylococcal vaccines to elicit antistaphylococcal alpha-hemolysin in dairy cows. J. Dairy Sci. 51, 1239–1242 (1968).
  Article CAS Google Scholar
• Elamanchili, P., Diwan, M., Cao, M. & Samuel, J. Characterization of poly(D,L-lactic-_co_-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells. Vaccine 22, 2406–2412 (2004).
  Article CAS Google Scholar
• Moon, J. J. et al. Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction. Proc. Natl Acad. Sci. USA 109, 1080–1085 (2012).
  Article CAS Google Scholar
• Inoshima, I. et al. A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice. Nature Med. 17, 1310–1314 (2011).
  Article CAS Google Scholar
• Moon, J. J., Huang, B. & Irvine, D. J. Engineering nano- and microparticles to tune immunity. Adv. Mater. 24, 3724–3746 (2012).
  Article CAS Google Scholar
• Swartz, M. A., Hirosue, S. & Hubbell, J. A. Engineering approaches to immunotherapy. Sci. Transl. Med. 4, 148rv149 (2012).
  Article Google Scholar
• Reddy, S. T. et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nature Biotechnol. 25, 1159–1164 (2007).
  Article CAS Google Scholar
• Hubbell, J. A., Thomas, S. N. & Swartz, M. A. Materials engineering for immunomodulation. Nature 462, 449–460 (2009).
  Article CAS Google Scholar
• Parodi, A. et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nature Nanotech. 8, 61–68 (2013).
  Article CAS Google Scholar